当前位置: 首页 >> 检索结果
共有 3606 条符合本次的查询结果, 用时 1.2921838 秒

3101. Standard Dose Ivermectin for COVID-19.

作者: Dora Buonfrate.;Zeno Bisoffi.
来源: Chest. 2021年159卷5期2111-2112页

3102. Remarks About Retrospective Analysis of Ivermectin Effectiveness on Coronavirus Disease 2019 (ICON Study).

作者: Eduardo Ortega-Guillén.;Giovanni Meneses.;Edgar Coila.
来源: Chest. 2021年159卷5期2110-2111页

3103. Response.

作者: Sonali Narain.;Dimitre G Stefanov.;Galina Marder.;Blanka Kaplan.;Negin Hajizadeh.
来源: Chest. 2021年159卷5期2109-2110页

3104. Response.

作者: Hugo J A Adams.;Thomas C Kwee.;Robert M Kwee.
来源: Chest. 2021年159卷5期2108页

3105. Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One.

作者: Chia Siang Kow.;Syed Shahzad Hasan.
来源: Chest. 2021年159卷5期2108-2109页

3106. Should Vascular Abnormalities Be Integrated Into the Chest CT Imaging Signature of Coronavirus Disease 2019?

作者: David C Rotzinger.;Salah D Qanadli.
来源: Chest. 2021年159卷5期2107-2108页

3107. The Evaluation of DHR Histogram Pattern in Chronic Granulomatous Disease and MPO Deficiency.

作者: Mustafa Yavuz Köker.;Sevil Özsoy.;Huriye Çelikzencir.;Nezihe Köker.
来源: Chest. 2021年159卷5期2106页

3108. Lung Cancer: Why the Stigma? And What Can Be Done?

作者: Liz Scharnetzki.;Joan H Schiller.
来源: Chest. 2021年159卷5期1721-1722页

3109. Increased Risk and Improved Survival: The Double-Edged Sword of Lung Cancer in Women.

作者: Christina R MacRosty.;M Patricia Rivera.
来源: Chest. 2021年159卷5期1719-1720页

3110. Does CPAP Improve Chronic Kidney Disease in OSA?: It's Still a Maybe.

作者: Sheila Sivam.;Richard Singer.;Brendon John Yee.
来源: Chest. 2021年159卷5期1717-1718页

3111. What We Might Find If We Only Looked.

作者: Michael J Lanspa.;Samuel M Brown.
来源: Chest. 2021年159卷5期1715-1716页

3112. Finding Needles in a Haystack: Progress Toward Identifying Pulmonary Arterial Hypertension With the Use of Administrative Data.

作者: Evan L Brittain.;Sean J Callahan.
来源: Chest. 2021年159卷5期1713-1714页

3113. Immersion Pulmonary Edema.

作者: Peter Wilmshurst.
来源: Chest. 2021年159卷5期1711-1712页

3114. A Comprehensive Family Health History and Genetic Analyses Are Complementary in the Detection of Risk for Progressive Pulmonary Fibrosis.

作者: Michelle Terwiel.;Coline H M van Moorsel.
来源: Chest. 2021年159卷5期1709-1710页

3115. Ventilation During Cardiopulmonary Bypass: Can We, Must We, Should We Individualize It?

作者: Marcus J Schultz.;Vasileios Zochios.;Ary Serpa Neto.
来源: Chest. 2021年159卷5期1703-1705页

3116. Administrative Databases Are Here to Stay.

作者: Raquel Barba.
来源: Chest. 2021年159卷5期1701-1702页

3117. Lung Cancer Screening, Emphysema, and COPD.

作者: Mario Mascalchi.;Michaela Luconi.
来源: Chest. 2021年159卷5期1699-1700页

3118. Elastic Resistance Exercises: Making Pulmonary Rehabilitation More Accessible?

作者: Daniel Langer.
来源: Chest. 2021年159卷5期1696-1698页

3119. One Size Does Not Fit All: Moving Towards a Personalized Approach for Steroids in COVID-19.

作者: Francesco Amati.;Charles S Dela Cruz.
来源: Chest. 2021年159卷5期1693-1695页

3120. Comparison of Profiles of First Nations and Non-First Nations Children With Bronchiectasis Over Two 5-Year Periods in the Northern Territory, Australia.

作者: Gabrielle B McCallum.;Victor M Oguoma.;Lesley A Versteegh.;Cate A Wilson.;Paul Bauert.;Brian Spain.;Anne B Chang.
来源: Chest. 2021年160卷4期1200-1210页
Although the burden of bronchiectasis is recognized globally, pediatric data are limited, particularly on trends over the years. Also, no published data exists regarding whether vitamin D deficiency or insufficiency and human T-cell lymphotropic virus type 1 (HTLV-1) infection, both found to be related to severe bronchiectasis in First Nations adults, also are important in children with bronchiectasis.
共有 3606 条符合本次的查询结果, 用时 1.2921838 秒